{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:07:00Z","timestamp":1791112020725,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"},{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/cddis.2014.281","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T12:45:05Z","timestamp":1404391505000},"page":"e1316-e1316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells"],"prefix":"10.1038","volume":"5","author":[{"given":"J","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,3]]},"reference":[{"key":"BFcddis2014281_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"BFcddis2014281_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A . Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9\u201329.","journal-title":"CA Cancer J Clin"},{"key":"BFcddis2014281_CR3","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","volume":"26","author":"GV Scagliotti","year":"2008","unstructured":"Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008; 26: 3543\u20133551.","journal-title":"J Clin Oncol"},{"key":"BFcddis2014281_CR4","first-page":"3321","volume":"53","author":"TC Fisher","year":"1993","unstructured":"Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA et al. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 1993; 53: 3321\u20133326.","journal-title":"Cancer Res"},{"key":"BFcddis2014281_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0163-7258(84)90024-X","volume":"25","author":"RC Jackson","year":"1984","unstructured":"Jackson RC . Biological effects of folic acid antagonists with antineoplastic activity. Pharmacol Ther 1984; 25: 61\u201382.","journal-title":"Pharmacol Ther"},{"key":"BFcddis2014281_CR6","first-page":"129","volume":"44","author":"RM Schultz","year":"1995","unstructured":"Schultz RM . Newer antifolates in cancer therapy. Prog Drug Res 1995; 44: 129\u2013157.","journal-title":"Prog Drug Res"},{"key":"BFcddis2014281_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/sj.leu.2404599","volume":"21","author":"JM Ramirez","year":"2007","unstructured":"Ramirez JM, Ocio EM, San Miguel JF, Pandiella A . Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosis. Leukemia 2007; 21: 797\u2013804.","journal-title":"Leukemia"},{"key":"BFcddis2014281_CR8","first-page":"2677","volume":"6","author":"HL McLeod","year":"2000","unstructured":"McLeod HL, Cassidy J, Powrie RH, Priest DG, Zorbas MA, Synold TW et al. Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034. Clin Cancer Res 2000; 6: 2677\u20132684.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2014281_CR9","first-page":"2114","volume":"7","author":"X Lu","year":"2001","unstructured":"Lu X, Errington J, Curtin NJ, Lunec J, Newell DR . The impact of p53 status on cellular sensitivity to antifolate drugs. Clin Cancer Res 2001; 7: 2114\u20132123.","journal-title":"Clin Cancer Res"},{"key":"BFcddis2014281_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s002800050608","volume":"39","author":"JL Tonkinson","year":"1997","unstructured":"Tonkinson JL, Marder P, Andis SL, Schultz RM, Gossett LS, Shih C et al. Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis. Cancer Chemother Pharmacol 1997; 39: 521\u2013531.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFcddis2014281_CR11","first-page":"1116","volume":"57","author":"C Shih","year":"1997","unstructured":"Shih C, Chen VJ, Gossett LS, Gates SB, MacKellar WC, Habeck LL et al. LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res 1997; 57: 1116\u20131123.","journal-title":"Cancer Res"},{"key":"BFcddis2014281_CR12","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.ejca.2011.06.003","volume":"47","author":"L Su","year":"2011","unstructured":"Su L, Liu G, Hao X, Zhong N, Zhong D, Liu X et al. Death receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cells. Eur J Cancer 2011; 47: 2471\u20132478.","journal-title":"Eur J Cancer"},{"key":"BFcddis2014281_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nrc2663","volume":"9","author":"TG Cotter","year":"2009","unstructured":"Cotter TG . Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer 2009; 9: 501\u2013507.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2014281_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0092-8674(00)00187-2","volume":"103","author":"DC Huang","year":"2000","unstructured":"Huang DC, Strasser A . BH3-only proteins-essential initiators of apoptotic cell death. Cell 2000; 103: 839\u2013842.","journal-title":"Cell"},{"key":"BFcddis2014281_CR15","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.cell.2007.04.027","volume":"129","author":"H Puthalakath","year":"2007","unstructured":"Puthalakath H, O'Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 2007; 129: 1337\u20131349.","journal-title":"Cell"},{"key":"BFcddis2014281_CR16","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/ijc.21751","volume":"119","author":"T Shibue","year":"2006","unstructured":"Shibue T, Taniguchi T . BH3-only proteins: integrated control point of apoptosis. Int J Cancer 2006; 119: 2036\u20132043.","journal-title":"Int J Cancer"},{"key":"BFcddis2014281_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393\u2013403.","journal-title":"Mol Cell"},{"key":"BFcddis2014281_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1593\/neo.07589","volume":"9","author":"Y Mei","year":"2007","unstructured":"Mei Y, Xie C, Xie W, Tian X, Li M, Wu M . Noxa\/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis. Neoplasia 2007; 9: 871\u2013881.","journal-title":"Neoplasia"},{"key":"BFcddis2014281_CR19","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1517\/13543784.2011.609167","volume":"20","author":"BA Quinn","year":"2011","unstructured":"Quinn BA, Dash R, Azab B, Sarkar S, Das SK, Kumar S et al. Targeting Mcl-1 for the therapy of cancer. Expert Opin Investig Drugs 2011; 20: 1397\u20131411.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFcddis2014281_CR20","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1101\/gad.1093903","volume":"17","author":"D Nijhawan","year":"2003","unstructured":"Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003; 17: 1475\u20131486.","journal-title":"Genes Dev"},{"key":"BFcddis2014281_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.18632\/oncotarget.242","volume":"2","author":"H Inuzuka","year":"2011","unstructured":"Inuzuka H, Fukushima H, Shaik S, Liu P, Lau AW, Wei W . Mcl-1 ubiquitination and destruction. Oncotarget 2011; 2: 239\u2013244.","journal-title":"Oncotarget"},{"key":"BFcddis2014281_CR22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature08646","volume":"463","author":"M Schwickart","year":"2010","unstructured":"Schwickart M, Huang X, Lill JR, Liu J, Ferrando R, French DM et al. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature 2010; 463: 103\u2013107.","journal-title":"Nature"},{"key":"BFcddis2014281_CR23","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1073\/pnas.0807611106","volume":"106","author":"Q Wang","year":"2009","unstructured":"Wang Q, Mora-Jensen H, Weniger MA, Perez-Galan P, Wolford C, Hai T et al. ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells. Proc Natl Acad Sci USA 2009; 106: 2200\u20132205.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014281_CR24","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1016\/j.bbamcr.2013.06.028","volume":"1833","author":"R Sano","year":"2013","unstructured":"Sano R, Reed JC . ER stress-induced cell death mechanisms. Biochim Biophys Acta 2013; 1833: 3460\u20133470.","journal-title":"Biochim Biophys Acta"},{"key":"BFcddis2014281_CR25","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1038\/cddis.2012.87","volume":"3","author":"S Kawabata","year":"2012","unstructured":"Kawabata S, Gills JJ, Mercado-Matos JR, Lopiccolo J, Wilson W 3rd, Hollander MC et al. Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells. Cell Death Dis 2012; 3: e353.","journal-title":"Cell Death Dis"},{"key":"BFcddis2014281_CR26","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.1090072","volume":"302","author":"A Villunger","year":"2003","unstructured":"Villunger A, Michalak EM, Coultas L, M\u00fcllauer F, B\u00f6ck G, Ausserlechner MJ et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003; 302: 1036\u20131038.","journal-title":"Science"},{"key":"BFcddis2014281_CR27","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1038\/onc.2010.559","volume":"30","author":"H Zhang","year":"2011","unstructured":"Zhang H, Guttikonda S, Roberts L, Uziel T, Semizarov D, Elmore SW et al. Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines. Oncogene 2011; 30: 1963\u20131968.","journal-title":"Oncogene"},{"key":"BFcddis2014281_CR28","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1073\/pnas.0701297104","volume":"104","author":"PE Czabotar","year":"2007","unstructured":"Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DC et al. Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci USA 2007; 104: 6217\u20136222.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2014281_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.bbrc.2011.08.118","volume":"413","author":"P Gomez-Bougie","year":"2011","unstructured":"Gomez-Bougie P, M\u00e9noret E, Juin P, Dousset C, Pellat-Deceunynck C, Amiot M . Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1\/USP9X interaction. Biochem Biophys Res Commun 2011; 413: 460\u2013464.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcddis2014281_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3727\/096504001108747729","volume":"12","author":"HH Backus","year":"2000","unstructured":"Backus HH, Pinedo HM, Wouters D, Kuiper CM, Jansen G, van Groeningen CJ et al. Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolates. Oncol Res 2000; 12: 231\u2013239.","journal-title":"Oncol Res"},{"key":"BFcddis2014281_CR31","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/jnci\/djh322","volume":"96","author":"X Liu","year":"2004","unstructured":"Liu X, Yue P, Zhou Z, Khuri FR, Sun SY . Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 2004; 96: 1769\u20131780.","journal-title":"J Natl Cancer Inst"},{"key":"BFcddis2014281_CR32","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/j.1582-4934.2011.01401.x","volume":"16","author":"G Liu","year":"2012","unstructured":"Liu G, Su L, Hao X, Zhong N, Zhong D, Singhal S et al. Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells. J Cell Mol Med 2012; 16: 1618\u20131628.","journal-title":"J Cell Mol Med"}],"container-title":["Cell Death & Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2014281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014281","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2014281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:19:35Z","timestamp":1672960775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2014281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,3]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7]]}},"alternative-id":["BFcddis2014281"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2014.281","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,3]]},"assertion":[{"value":"31 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}